Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  2004-06-04

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-004-1925-4PMID 15179544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Do antidepressants regulate how cortisol affects the brain?

  2004influential reference
• Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects.

  2004cited by this paper
• Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis

  2004cited by this paper
• Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters

  2003cited by this paper
• The Antidepressant Clomipramine Regulates Cortisol Intracellular Concentrations and Glucocorticoid Receptor Expression in Fibroblasts and Rat Primary Neurones

  2003cited by this paper
• Contrasting effects of citalopram and reboxetine on waking salivary cortisol

  2003cited by this paper
• Depression, Stress and the Adrenal axis

  2003cited by this paper
• ABCB1 (MDR1)-Type P-Glycoproteins at the Blood–Brain Barrier Modulate the Activity of the Hypothalamic–Pituitary–Adrenocortical System: Implications for Affective Disorder

  2003cited by this paper
• Acute citalopram administration produces correlated increases in plasma and salivary cortisol

  2002cited by this paper
• The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder.

  2002influential reference
• State and trait abnormalities in serotonin function in major depression.

  2002cited by this paper
• A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis.

  2002influential reference
• Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain.

  2001cited by this paper
• Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus.

  2001cited by this paper
• Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.

  2001influential reference
• Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

  2001cited by this paper
• Low-dose citalopram as a 5-HT neuroendocrine probe

  2001influential reference
• Reboxetine in a neuroendocrine challenge paradigm: evidence for high cortisol responses in healthy volunteers scoring high on subclinical depression.

  2000cited by this paper
• Tissue specificity of glucocorticoid sensitivity in healthy adults.

  2000influential reference
• Prednisone augmentation in treatment‐resistant depression with fatigue and hypocortisolaemia: A case series

  2000cited by this paper
• The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone

  2000cited by this paper
• Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers.

  2000cited by this paper
• Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study.

  2000cited by this paper
• Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

  1998cited by this paper
• Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays

  1998cited by this paper
• Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans.

  1997cited by this paper
• Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system.

  1997cited by this paper
• Dexamethasone augmentation in treatment‐resistant depression

  1997cited by this paper
• Neuroendocrine Effects of a 20-mg Citalopram Infusion in Healthy Males

  1996influential reference
• Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects.

  1996cited by this paper
• Long‐Term Antidepressant Treatment Reduces Behavioural Deficits in Transgenic Mice with Impaired Glucocorticoid Receptor Function

  1995cited by this paper
• Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder.

  1995influential reference
• Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.

  1993cited by this paper
• Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

  1993cited by this paper
• The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications.

  1992cited by this paper
• The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis.

  1991cited by this paper
• Comparisons of plasma and salivary cortisol determinations for the diagnostic efficacy of the dexamethasone suppression test.

  1990influential reference
• The influence of psychotropic drugs and releasing hormones on anterior pituitary hormone secretion in healthy subjects and depressed patients.

  1990cited by this paper
• Serotonin in panic disorder: platelet uptake and concentration.

  1989cited by this paper
• Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls.

  1989cited by this paper
• 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment.

  1987cited by this paper
• The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review.

  1985influential reference
• A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.

  1976cited by this paper
• ADRENAL cortex.

  1955cited by this paper

• Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume

  2024cites this paper
• Ecological validity of social defeat stressors in mouse models of vulnerability and resilience.

  2023cites this paper
• The Role of Hypothalamic-Pituitary-Adrenal Axis in the Pathophysiology of Major Depression: A Translational Research Perspective of the Prednisolone Suppression Test

  2022cites this paper
• GLUCOCORTICOID-RELATED mRNAs CORRECTLY SEPARATES

  2020cites this paper
• Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study

  2020cites this paper
• Depression and inflammation: implications for cardiovascular disease

  2020cites this paper
• In vivo Calcium Imaging Reveals That Cortisol Treatment Reduces the Number of Place Cells in Thy1-GCaMP6f Transgenic Mice

  2019cites this paper
• Childhood trauma, HPA axis activity and antidepressant response in patients with depression

  2019cites this paper
• Chronic effects of pre-adolescent pharmacological and non-pharmacological interventions on depressive-like behaviour in rats

  2018cites this paper
• The effects of six-day SSRI administration on diurnal cortisol secretion in healthy volunteers

  2018cites this paper
• Psychosocial stress and cardiovascular disease: The role of the hypothalamic-pituitary-adrenal axis

  2017cites this paper
• Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation.

  2017cites this paper
• A parallel universe where psychiatry is like the rest of medicine

  2017cites this paper
• Chapter 27 - Antidepressant Actions on Glucocorticoid Receptors A2

  2017cites this paper
• Therapeutic effects of 10‐HzPulsed wave lasers in rat depression model: A comparison between near‐infrared and red wavelengths

  2016cites this paper
• HPA axis and aging in depression: systematic review and meta-analysis.

  2014cites this paper
• Early-life stress and HPA axis trigger recurrent adulthood depression.

  2014cites this paper
• State of the Science: Salivary Biomarker Utilization for Stress Research

  2014cites this paper
• Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

  2013cites this paper
• Exploring the Pathophysiology of Chronic Depression: The Interplay between Depression, Cortisol Responses, and Personality

  2013cites this paper
• Salivary Cortisol as a Biomarker in Social Science Research

  2013cites this paper
• Central glucocorticoid receptor-mediated effects of the antidepressant, citalopram, in humans: a study using EEG and cognitive testing.

  2012cites this paper
• The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.

  2012cites this paper
• Salivary biomarkers in stress research

  2012cites this paper
• Escitalopram and Neuroendocrine Response in Healthy First-Degree Relatives to Depressed Patients – A Randomized Placebo-Controlled Trial

  2011cites this paper
• Spatial memory processes in bipolar depression : neuropsychological and HPA axis correlates

  2011cites this paper
• Saliva DHEA and cortisol responses following short‐term corticosteroid intake

  2010cites this paper
• Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.

  2010cites this paper
• The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment.

  2010cites this paper
• Neuroendocrine effects of Citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans

  2010cites this paper
• Glucocorticoid Receptor Polymorphisms in Major Depression

  2009cites this paper
• Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge.

  2009cites this paper
• Modulation of stress by imidazoline binding sites: Implications for psychiatric disorders

  2009cites this paper
• Response Prediction von und neuroendokrinologische Veränderungen unter antidepressiver Pharmakotherapie mit Citalopram. Eine Untersuchung mit dem kombinierten Dexamethason/CRH-Test bei monopolar depressiv erkrankten Patienten.

  2009cites this paper
• Clomipramine In Vitro Reduces Glucocorticoid Receptor Function in Healthy Subjects but not in Patients with Major Depression

  2008cites this paper
• A multi-hit endocrine model of intrinsic adult-onset asthma.

  2008cites this paper
• In vitro modulation of the glucocorticoid receptor by antidepressants

  2008cites this paper
• The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.

  2008cites this paper
• Affective-related endophenotypes in serotonin transporter over-expressing mice

  2008cites this paper
• The Antidepressant Desipramine Requires the ABCB1 (Mdr1)-Type p-Glycoprotein to Upregulate the Glucocorticoid Receptor in Mice

  2007cites this paper
• Neuroendocrinological Mechanisms of Actions of Antidepressant Drugs

  2007cites this paper
• Resposta neuroendócrina aguda ao citalopram e resposta terapêutica no transtorno obsessivo-compulsivo

  2007cites this paper
• Acute hormonal changes after IV citalopram and treatment response in OCD

  2007cites this paper
• Neuroendocrine effects of citalopram infusion in anorexia nervosa.

  2006cites this paper
• The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.

  2006cites this paper
• Involvement of the Endocannabinoid System in the Ability of Long-Term Tricyclic Antidepressant Treatment to Suppress Stress-Induced Activation of the Hypothalamic–Pituitary–Adrenal Axis

  2006cites this paper
• Different responses to dexamethasone and prednisolone in the same depressed patients

  2006influential citation
• The effects of antidepressants on the hypothalamic-pituitary-adrenal axis.

  2006cites this paper
• Effects of Antidepressants on the Brain/Plasma Distribution of Corticosterone

  2006cites this paper
• Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients

  2006cites this paper
• The glucocorticoid receptor: part of the solution or part of the problem?

  2006cites this paper
• A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.

  2005cites this paper
• Current awareness in human psychopharmacology.

  2005cites this paper
• Cortisol in Chicago (from crime of passion to celebrity headline)

  2005cites this paper
• Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response

  2005influential citation
• The effects of physical and psychological stress on the behaviour and neurochemistry of rats

  2005cites this paper
• Glucocorticoid Receptor Function In Vitro in Patients with Major Depression

  2004influential citation
• Trials Open Access Rationale and Design of the Participant, Investigator, Observer, and Data-analyst-blinded Randomized Agenda Trial on Associations between Gene-polymorphisms, Endophenotypes for Depression and Antidepressive Intervention: the Effect of Escitalopram versus Placebo on the Combined De

  year unknowncites this paper